Clinical Trial Update: The Effect of Bacille Calmette Guerin (BCG) Vaccination on Immune Responses in HIV-Exposed and Unexposed Infants [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/Phase 2 study evaluating the effect of Bacillus Calmette-Guérin (BCG) vaccination on immune responses in HIV-exposed and unex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bacille Calmette-Guérin vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Stellenbosch | Conditions: HIV Infections | Phase 1, Phase 2 | Status: UNKNOWN